MCL1 and acute myeloid leukemia: As MCL-1 is critical for the sustained survival and expansion of mouse as well as human AML cells [20], targeting the intrinsic apoptotic pathway through MCL-1 antagonism is a rational strategy to restore apoptosis in AML cells.